Afrifund
Menu
About Us
Consulting
Our Team
Our Philosophy
Our Group Structure
Our Vision
Our Thesis
News & Insights
Contact Us
BioNTech/Pfizer vaccine may be less effective against Omicron, study finds
South African researchers report ‘extensive but incomplete’ reduction in immune protection